DNA Vaccine Market By Source (Humans, Animals, Others), by Technology (pDNA delivery technology, pDNA vaccines technology), by Application (Human diseases, Veterinary diseases), Industry Trends, Estimation & Forecast, 2017 - 2025

July 2018

 Pages: 185

 ERC 8832


DNA Vaccine Market is expected to grow with a CAGR of 40% during the forecast period of 2018 to 2025.

Technological advancements in the medical sector have led to the advent of third generation vaccines such as DNA, viral/bacterial vectored, and autologous proteins. DNA vaccine is an emerging vaccine type having several benefits such as usage of multiple genes to enhance immunity, specific targeting, and low risk rates as compared to the traditional vaccines. However, the translation of these benefits into actual clinical applications is still in pipeline and is expected to render lucrative opportunities to the market players during the upcoming years. Several clinical and preclinical trials are under process due to which, till date, only a small portion of the DNA vaccines has entered into the commercial market.

The emergence of nouveau biotechnology and nanotechnology trends such as electroporation, novel molecular adjuvant technologies, and DNA prime-adenovector boost are fuelling the development rate of DNA vaccines. In terms of region, the developed nations are expected to gain a higher market share as compared to the developing nations, owing to the low penetration of DNA vaccines in the developing nations. The absence of fixed regulatory systems and low investment in modern medical therapies are anticipated to create hurdles in the growth of global DNA vaccine market.

The report provides detailed qualitative and quantitative analysis of the DNA vaccine market. Market size and forecast in terms of value and volume has been provided for the period - (2017–2025) for the segments namely source, technology and application in each of the major regions.

DNA Vaccine Market Player Analysis

The report presents detailed analysis of major players operating in DNA vaccine market. Few of them include Vical Inc., Novartis Animal Health, Inovio Biomedical Corp., Dendreon Corporation, Astellas Pharma, Merck & Co., GlaxoSmithKline Inc., Sanofi, Xenetic Biosciences Inc., Tekmira Pharmaceuticals, Indian Immunologicals Ltd, Pfizer Pharmaceuticals, Tolerion Inc., QED Biosciences Inc., and Advance Bioscience Laboratories Inc. Detailed coverage on these market players with information on their revenue from DNA vaccine business, market share, gross margin and their growth strategies have been provided in the report.

DNA Vaccine Market Segmentation

DNA vaccine market is segmented on the basis of source, technology, application, and geography. By source, the market is segmented into humans, animals, and others. Based on technology, the market is categorized into pDNA delivery technology and pDNA vaccines technology. By application, the market is bifurcated into human diseases and veterinary diseases. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

DNA Vaccine Market Segmentation

By Source
By Technology
•pDNA delivery technology
•pDNA vaccines technology
By Application
•Human diseases
•Veterinary diseases
By Geography
•North America
oRest of Europe
oRest of APAC
•South America
oRest of South America
•Rest of the World
oMiddle East
DNA Vaccine Market Key Players
•Vical Inc.
•Novartis Animal Health
•Inovio Biomedical Corp.
•Dendreon Corporation
•Astellas Pharma
•Merck & Co.
•GlaxoSmithKline Inc.
•Xenetic Biosciences Inc.
•Tekmira Pharmaceuticals
•Indian Immunologicals Ltd
•Pfizer Pharmaceuticals
•Tolerion Inc.
•QED Biosciences Inc.
•Advance Bioscience Laboratories Inc.

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the DNA Vaccine Market in 2016 and the expected market size by 2024, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2016 - 2024)?
    • Which are the leading companies in the DNA Vaccine Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!